| RMFCX | USISX | RMFCX / USISX | |
| Total Expense Ratio | 0.91 | 0.75 | 121% |
| Annual Report Gross Expense Ratio | 0.91 | 0.75 | 121% |
| Fund Existence | 24 years | 39 years | - |
| Gain YTD | 5.845 | 11.671 | 50% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 3000 | 8% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 115B | 2.74B | 4,202% |
| Annual Yield % from dividends | 1.19 | 1.76 | 68% |
| Returns for 1 year | 10.10 | 16.05 | 63% |
| Returns for 3 years | 34.65 | 25.97 | 133% |
| Returns for 5 years | 33.85 | 11.32 | 299% |
| Returns for 10 years | 91.46 | 35.27 | 259% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| OILT | 30.40 | 0.27 | +0.90% |
| Texas Capital Texas Oil Index ETF | |||
| IDEV | 90.66 | 0.56 | +0.62% |
| iShares Core MSCI Intl Dev Mkts ETF | |||
| AOK | 41.55 | 0.07 | +0.16% |
| iShares Core 30/70 Cnsrv Allc ETF | |||
| EJAN | 36.09 | -0.01 | -0.02% |
| Innovator Emerging Mkt Pwr Buff ETF™ Jan | |||
| HEAL | 24.95 | -0.59 | -2.31% |
| Global X HealthTech ETF | |||